Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Biochimica Et Biophysica Acta. Molecular Cell Research|February 18, 2021
It's time to die: BH3 mimetics in solid tumorsSarah Kehr, Meike VoglerOncogene|June 3, 2018
BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosisUlrike Heinicke, Tinka Haydn, Sarah Kehr, et al.International Journal of Cancer|November 23, 2019
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cellsTinka Haydn, Sarah Kehr, Dominica Willmann, et al.Cancer Letters|March 8, 2020
Targeting BCL-2 proteins in pediatric cancer: Dual inhibition of BCL-X<sub>L</sub> and MCL-1 leads to rapid induction of intrinsic apoptosisSarah Kehr, Tinka Haydn, Annika Bierbrauer, et al.Journal of Assisted Reproduction and Genetics|May 26, 2026
Embryo mix-up due to erroneous identification in the context of medically assisted reproductionFrancisca N Amoah, Sarah Kehr, Susanne Müller, et al.Vox Sanguinis|June 18, 2024
A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance dataPhilipp Berg, Margarethe Heiden, Susanne Müller, et al.NPJ Vaccines|July 5, 2022
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosisSarah Kehr, Philipp Berg, Susanne Müller, et al.Cell Death Discovery|January 11, 2022
Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapyVinzenz Särchen, Senthan Shanmugalingam, Sarah Kehr, et al.Pageof 1